What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
Stefan Zeuzem mostly deals with Internal medicine, Gastroenterology, Hepatitis C virus, Immunology and Ribavirin.
His research is interdisciplinary, bridging the disciplines of Viral load and Internal medicine.
His Gastroenterology research integrates issues from Randomized controlled trial, Surgery, Peginterferon alfa-2a, Sofosbuvir and Placebo.
His Hepatitis C virus study integrates concerns from other disciplines, such as Alpha interferon and Genotype.
The various areas that he examines in his Ribavirin study include Interferon and Pharmacology.
His work in Hepatitis C addresses subjects such as Voxilaprevir, which are connected to disciplines such as Pibrentasvir and Glecaprevir.
His most cited work include:
- Sorafenib in Advanced Hepatocellular Carcinoma (7596 citations)
- Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. (2656 citations)
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus (2258 citations)
What are the main themes of his work throughout his whole career to date?
Stefan Zeuzem focuses on Internal medicine, Gastroenterology, Hepatitis C virus, Ribavirin and Immunology.
Internal medicine connects with themes related to Pegylated interferon in his study.
His Gastroenterology research is multidisciplinary, relying on both Placebo, Chronic hepatitis and Regimen, Surgery.
The study incorporates disciplines such as Interferon, Viral load and Genotype in addition to Hepatitis C virus.
His studies deal with areas such as Alpha interferon and Combination therapy, Pharmacology as well as Ribavirin.
His Hepatitis C research includes elements of Viral hepatitis, Clinical trial and Hepatitis.
He most often published in these fields:
- Internal medicine (51.42%)
- Gastroenterology (33.88%)
- Hepatitis C virus (27.09%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (51.42%)
- Gastroenterology (33.88%)
- Cirrhosis (15.06%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Gastroenterology, Cirrhosis, Hepatitis C and Hepatitis C virus.
His research links Chronic hepatitis with Internal medicine.
His Gastroenterology research incorporates themes from Hepatitis B, Regimen, Hepatocellular carcinoma, Grazoprevir and Elbasvir.
His Cirrhosis research incorporates elements of Inflammation, Systemic inflammation, Immunology, Liver disease and Innate immune system.
He combines subjects such as Elbasvir, Grazoprevir, Ribavirin, Meta-analysis and Hepatitis with his study of Hepatitis C.
Stefan Zeuzem usually deals with Hepatitis C virus and limits it to topics linked to Genotype and Virology.
Between 2018 and 2021, his most popular works were:
- Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial (47 citations)
- Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis (44 citations)
- The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. (36 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Internal medicine, Gastroenterology, Cirrhosis, Hepatitis C virus and Hepatitis C are his primary areas of study.
Stefan Zeuzem incorporates Internal medicine and In patient in his research.
His biological study spans a wide range of topics, including Hepatitis B, Chronic hepatitis, Regimen, Adverse effect and Clinical endpoint.
His Cirrhosis research is multidisciplinary, incorporating elements of Bilirubin and Organ dysfunction.
His Hepatitis C virus study combines topics from a wide range of disciplines, such as Genotype and Hepatitis.
His research in Hepatitis C intersects with topics in Hepatocellular carcinoma, Guideline and Virologic response.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
